Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19
Аннотация: Abstract Background Acute kidney injury (AKI) occurs among patients with coronavirus disease-19 (COVID-19) and has also been indicated to be associated with in-hospital mortality. Remdesivir has been authorized for the treatment of COVID-19. We conducted a systematic review to evaluate the incidence of AKI in hospitalized COVID-19 patients. The incidence of AKI in different subgroups was also investigated. Methods A thorough search was performed to find relevant studies in PubMed, Web of Science, medRxiv and EMBASE from 1 Jan 2020 until 1 June 2020. The systematic review was performed using the meta package in R (4.0.1). Results A total of 16,199 COVID-19 patients were included in our systematic review. The pooled estimated incidence of AKI in all hospitalized COVID-19 patients was 10.0% (95% CI: 7.0–12.0%). The pooled estimated proportion of COVID-19 patients who needed continuous renal replacement therapy (CRRT) was 4% (95% CI: 3–6%). According to our subgroup analysis, the incidence of AKI could be associated with age, disease severity and ethnicity. The incidence of AKI in hospitalized COVID-19 patients being treated with remdesivir was 7% (95% CI: 3–13%) in a total of 5 studies. Conclusion We found that AKI was not rare in hospitalized COVID-19 patients. The incidence of AKI could be associated with age, disease severity and ethnicity. Remdesivir probably did not induce AKI in COVID-19 patients. Our systematic review provides evidence that AKI might be closely associated with SARS-CoV-2 infection, which should be investigated in future studies.
Год издания: 2021
Авторы: Zhenjian Xu, Ying Tang, Qiuyan Huang, Sha Fu, Xiaomei Li, Baojuan Lin, Anping Xu, Junzhe Chen
Издательство: BioMed Central
Источник: BMC Nephrology
Ключевые слова: COVID-19 Clinical Research Studies, Acute Kidney Injury Research, Muscle and Compartmental Disorders
Другие ссылки: BMC Nephrology (PDF)
BMC Nephrology (HTML)
DOAJ (DOAJ: Directory of Open Access Journals) (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
www.researchsquare.com (PDF)
doi.org (HTML)
PubMed (HTML)
BMC Nephrology (HTML)
DOAJ (DOAJ: Directory of Open Access Journals) (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
www.researchsquare.com (PDF)
doi.org (HTML)
PubMed (HTML)
Открытый доступ: gold
Том: 22
Выпуск: 1